Clinical Trials Directory

Trials / Conditions / High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

4 registered clinical trials studyying High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladd
NCT05962541
University of Roma La SapienzaPhase 4
RecruitingIDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for
NCT05843448
University of California, DavisPhase 1
UnknownHyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma
NCT05276167
Henan Cancer HospitalN/A
UnknownTilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which
NCT05418309
Tianjin Medical University Second HospitalPhase 2